KB
Kaushik Balakrishnan Natesan
About Kaushik Balakrishnan Natesan
Data last updated:
Kaushik Balakrishnan Natesan is a Cfo at Entero Healthcare Solutions Limited (since 2025) and Director at Curever Pharma Private Limited (since 2021). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹6,611 Cr; the largest is Entero Healthcare Solutions Limited at ₹6,610 Cr (FY 2026). Earlier, Kaushik Balakrishnan Natesan was a Director at Dhanvanthri Super Speciality Private Limited (2023–2025) and Director at Svmed Solutions Private Limited (2023–2025) and 18 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Entero Healthcare Solutions Limited L74999HR2018PLC072204 | Cfo | 11 Apr 2025 | 2018 | ₹6,610 Cr (FY 2026) | Active |
 Curever Pharma Private Limited U24230MH2021PTC353725 | Director | 19 Jan 2021 | 2021 | ₹56.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dhanvanthri Super Speciality Private Limited U46497KA2023PTC177243 | Director | 11 Dec 2023 | 2023 | ₹126 Cr (FY 2025) | Active |
| Svmed Solutions Private Limited U51397AP2019PTC111697 | Director | 26 Oct 2023 | 2019 | ₹80.80 Cr (FY 2025) | Active |
| Chethana Pharma Distributors Private Limited U51909KA2020PTC133694 | Director | 08 Apr 2020 | 2020 | Active | |
| Western Healthcare Solutions Private Limited U51909KL2021PTC068006 | Director | 01 Apr 2021 | 2021 | ₹156 Cr (FY 2025) | Active |
| Entero R.S. Enterprises Private Limited U46497KA2023PTC173357 | Director | 13 Dec 2023 | 2023 | ₹64.36 Cr (FY 2025) | Active |
| Calcutta Medisolutions Private Limited U51397WB2020PTC236018 | Director | 01 Jan 2021 | 2020 | ₹30.46 Cr (FY 2025) | Active |
| Sree Venkateshwara Medisolutions Private Limited U51900TG2020PTC139985 | Director | 15 Mar 2021 | 2020 | ₹45.59 Cr (FY 2025) | Active |
| Atreja Healthcare Solutions Private Limited U51909HR2021PTC092908 | Director | 22 Feb 2022 | 2021 | ₹22.28 Cr (FY 2025) | Active |
| Quromed Lifesciences Private Limited U51100MH2020PTC339126 | Director | 26 Mar 2020 | 2020 | Strike Off | |
| Rimedio Pharma Private Limited U51909MH2020PTC339123 | Director | 26 Mar 2020 | 2020 | Strike Off | |
| Zennx Software Solutions Private Limited U72900MH2021PTC371067 | Director | 09 Nov 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kaushik Balakrishnan Natesan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Sadhanandham | 08445197 | Entero Healthcare Solutions Limited | Nominee Director |
| Prabhat Agrawal | 07466382 | Entero Healthcare Solutions Limited | Managing Director |
| Prabhat Agrawal | Entero Healthcare Solutions Limited | Ceo | |
| Prem Sethi | 07077034 | Entero Healthcare Solutions Limited | Whole-Time Director |
| Sandhya Gadkari Sharma | 02005378 | Entero Healthcare Solutions Limited | Director |
| Sanu Vishal Kapoor | Entero Healthcare Solutions Limited | Company Secretary | |
| Sumona Chakraborty | 09597426 | Entero Healthcare Solutions Limited | Nominee Director |
| Vasudevan Sujesh | 08240092 | Entero Healthcare Solutions Limited | Director |
| Prashant Srivastava | 09755730 | Curever Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kaushik Balakrishnan Natesan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kaushik Balakrishnan Natesan
Kaushik Balakrishnan Natesan currently holds 2 directorships: Entero Healthcare Solutions Limited (Cfo, since 11 Apr 2025, revenue ₹6,610 Cr (FY 2026)); Curever Pharma Private Limited (Director, since 19 Jan 2021, revenue ₹56.8 Lakh (FY 2025)).
Kaushik Balakrishnan Natesan was first appointed on 06 Mar 2019 as Additional Director at Galaxystar Pharma Distributors Private Limited. The most recent appointment on record is 11 Apr 2025 at Entero Healthcare Solutions Limited.
The 2 current companies of Kaushik Balakrishnan Natesan that report revenue have a combined latest revenue of ₹6,611 Cr: Entero Healthcare Solutions Limited ₹6,610 Cr (FY 2026); Curever Pharma Private Limited ₹56.8 Lakh (FY 2025).
Kaushik Balakrishnan Natesan held 20 earlier board appointments: Dhanvanthri Super Speciality Private Limited (Director, 11 Dec 2023 to 30 Jun 2025); Svmed Solutions Private Limited (Director, 26 Oct 2023 to 30 Jun 2025); Chethana Pharma Distributors Private Limited (Director, 08 Apr 2020 to 24 May 2025); Western Healthcare Solutions Private Limited (Director, 01 Apr 2021 to 24 May 2025); Entero R.S. Enterprises Private Limited (Director, 13 Dec 2023 to 31 Mar 2025); and 15 more.
The current boards of Kaushik Balakrishnan Natesan's companies include Arun Sadhanandham (Entero Healthcare Solutions Limited), Prabhat Agrawal (Entero Healthcare Solutions Limited), Prabhat Agrawal (Entero Healthcare Solutions Limited), Prem Sethi (Entero Healthcare Solutions Limited), Sandhya Gadkari Sharma (Entero Healthcare Solutions Limited), Sanu Vishal Kapoor (Entero Healthcare Solutions Limited), among others.